Top Markets
Coin of the day
Sunwin Stevia International, Inc. Sunwin Stevia International, Inc.

Sunwin Stevia International, Inc.

SUWN
Rangering i aksjer #41454
Sunwin Stevia International, Inc. (SUWN) is a China-based company specializing... Sunwin Stevia International, Inc. (SUWN) is a China-based company specializing in the manufacture and distribution of natural sweetening agents and various pharmaceutical products, primarily serving the People's Republic of China. The company's operations are structured into two principal divisions: Stevioside, and Corporate and Other Pharmaceutical. Under its stevioside segment, Sunwin produces a diverse range of steviol glycoside compounds, with rebaudioside A and stevioside as their key active components. Its product offerings include Steviosin, a low-calorie stevia extract designed for medicinal use, and OnlySweet, a zero-calorie tabletop sweetener. These products are supplied to a broad clientele, encompassing food and drug manufacturers, ingredient distributors, and international trade companies. Additionally, the firm is involved in the production and sale of Metformin, a widely utilized medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. maintains its headquarters in Qufu, China.
Aksjekurs
$0.0001
Sist synkronisert: 2025-04-22
Markedsverdi
$19.96K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CN
Handel Sunwin Stevia International, Inc. (SUWN)
Inntekter for Sunwin Stevia International, Inc. (SUWN)
Inntekter i 2026 TTM: 0
Ifølge Sunwin Stevia International, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Sunwin Stevia International, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$2.10B -
US
$1.47B -
CN
$880.00M -
US
$820.00M -
US
- -
SG